Aspirin usage is associated with improved prosthetic infrainguinal bypass graft patency

Vascular

Volumn 22, Issue 2, 2014, Pages 105-111

  Gassman, A A ^a   Degner, B C ^a   Al Nouri, O ^a   Philippi, L ^b   Hershberger, R ^a   Halandras, P ^a   Aulivola, B ^a   Milner, R ^c  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

aspirin; bypass; infrainguinal; limb salvage; patency

Indexed keywords

ACETYLSALICYLIC ACID;

AGED; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CRITICAL LIMB ISCHEMIA; FOLLOW UP; GRAFT PATENCY; GRAFT SURVIVAL; HUMAN; INFORMATION PROCESSING; INFRAINGUINAL BYPASS; LIMB SALVAGE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTHETIC INFRAINGUINAL BYPASS GRAFT PATENCY; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ASPIRIN; BYPASS; INFRAINGUINAL; LIMB SALVAGE; PATENCY;

AMPUTATION; ASPIRIN; BLOOD VESSEL PROSTHESIS IMPLANTATION; COMORBIDITY; CRITICAL ILLNESS; GRAFT OCCLUSION, VASCULAR; HUMANS; ILLINOIS; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84898860113     PISSN: 17085381     EISSN: 1708539X     Source Type: Journal    
DOI: 10.1177/1708538112473977     Document Type: Article

References (9)

1. Hirsch AT,Haskal ZJ,Hertzer NR,et al.ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.Circulation. 2006;113:e463-654.
2. Henke PK,Blackburn S,Proctor MC,et al.Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality.J Vasc Surg. 2004;39:357-65.
3. Abbruzzese TA,Havens J,Belkin M,et al.Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts.J Vasc Surg. 2004;39:1178-85.
4. Ward RP,Leeper NJ,Kirkpatrick JN,Lang RM,Sorrentino MJ,Williams KA.The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery.Int J Cardiol. 2005;104:264-8.
5. Goodney PP,Nolan BW,Schanzer A,et al.Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England.Ann Vasc Surg. 2010;24:57-68.
6. Simons JP,Goodney PP,Nolan BW,Cronenwett JL,Messina LM,Schanzer A.Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia.J Vasc Surg. 2010;51:1419-24.
7. Conte MS.Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes.J Vasc Surg. 2010;52:96S-103S.
8. Brown J,Lethaby A,Maxwell H,Wawrzyniak AJ,Prins MH.Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.Cochrane Database Syst Rev. 2008;:CD000535.
9. Dorffler-Melly J,Buller HR,Koopman MM,Prins MH.Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.Cochrane Database Syst Rev. 2003;:CD000536.